Abstract
The molecular mechanisms potentially responsible for cadmium carcinogenesis were investigated by differential gene expression analysis of Balb/c-3T3 cells morphologically transformed with cadmium chloride. Differential display analysis of gene expression revealed overexpression of mouse Translation Initiation Factor 3 (TIF3; GenBank Accession Number AF 271072) and Translation Elongation Factor-1δ (TEF-1δ; GenBank Accession Number AF 304351) in the transformed cells compared with the control cells. The full length cDNAs for TIF3 and TEF-1δ were cloned and sequenced. Transfection of mammalian cells with an expression vector containing either TIF3 or TEF-1δ cDNA resulted in overexpression of the encoded protein. Overexpression of the cDNA-encoded TIF3 and TEF-1δ proteins in NIH3T3 cells was oncogenic as evidenced by the appearance of transformed foci capable of anchorage-independent growth on soft agar and tumorigenesis in nude mouse. Blocking the translation of TIF3 and TEF-1δ proteins using the corresponding antisense mRNA resulted in a significant reversal of the oncogenic potential of cadmium transformed Balb/c-3T3 cells as evidenced from the suppression of anchorage-independent growth on soft agar and diminished tumorigenesis in nude mouse. These findings demonstrate that the up-regulation of expression of TIF3 and TEF-1δ is a novel molecular mechanism responsible, at least in part, for cadmium carcinogenesis.
Similar content being viewed by others
References
International Agency for Research on Cancer: Beryllium, cadmium, mercury and exposures in glass manufacturing industry. Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 58. International Agency for Research on Cancer, Lyon, France, 1993, pp 403–420
Thun MJ, Elinder C-G, Friberg L: Scientific basis for an occupational standard for cadmium. Am J Ind Med 20: 629–642, 1991
Waalkes MP, Coogan TP, Barter RA: Toxicological principles of metal carcinogenesis with special emphasis on cadmium. Crit Rev Toxicol 22: 175–201, 1992
Waalkes MP: Cadmium carcinogenesis in review. J Inorg Biochem 79: 241–244, 2000
Snow ET: Metal carcinogenesis: Mechanistic implications. Pharmacol Ther 53: 31–65, 1992
Joseph P, Lei YX, Whong WZ, Ong TM: Oncogenic potential of mouse translation elongation factor-1δ, a novel cadmium-responsive proto-oncogene. J Biol Chem 277: 6131–6136, 2002
Joseph P, Lei YX, Whong WZ, Ong TM: Molecular cloning and functional analysis of a novel cadmium-responsive proto-oncogene. Cancer Res 62: 703–707, 2002
Lei Y-X, Joseph P, Ong TM: Antisense inhibition of translation initiation factor 3 reverses its oncogenic potential. Teratogen Carcinogen Mutagen 22: 403–409, 2002
Barrett JC, Hesterberg TW, Thomassen DG: Use of cell transformation system for carcinogenicity testing and mechanistic studies of carcinogens. Pharmacol Rev 36: 53S–70S, 1984
Keshava N, Zhou G, Hubbs AF, Ensell M-X, Ong TM: Transforming and carcinogenic potential of cadmium chloride in BALB/c-3T3 cells. Mutat Res 448: 23–28, 2000
Land H, Parada LF, Weinberg RA: Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596–602, 1983
Anand N, Murthy S, Amann G, Wernick M, Porter LA, Cukier IH, Collins C, Gray JW, Diebold J, Demetrick DJ, Lee JM: Gene encoding protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat Genet 31: 301–305, 2002
Matsuoka M, Call KM: Cadmium-induced expression of immediate early genes in LLC-PK1 cells. Kidney Int 48: 383–389, 1995
Joseph P, Muchnok TK, Klishis ML, Roberts JR, Antonini JM, Whong W-Z, Ong TM: Cadmium-induced cell transformation and tumorigenesis are associated with transcriptional activation of c-fos, c-jun and c-myc proto-oncogenes: Role of cellular calcium and reactive oxygen species. Toxicol Sci 61: 295–303, 2001
Palmiter R.D: Molecular biology of metallothionein gene expression. In: H.R. Kagi, Y. Kojima (eds). Metallothionein II. Burkhauser Verlag, Basel, 1987, pp 63–80.
Abe T, Yamamoto O, Gotoh S, Yan Y, Todaka, N, Higashi K: Cadmium-induced mRNA expression of Hsp32 is augmented in metallothionein-I and-II knock-out mice. Arch Biochem Biophys 382: 81–88, 2000
Liu J, Kadiiska MB, Corton C, Qu W, Waalkes MP, Mason RP, Liu Y, Klaassen CD: Acute cadmium exposure induces stress-related gene expression in wild-type and metallothionein-I/II-null mice. Free Radical Biol Med 32: 525–535, 2002
Chin TA, Templeton DM: Protective elevations of glutathione and metallothionein in cadmium-exposed mesangial cells. Toxicology 77: 145–156, 1993
Eneman JD, Potts RJ, Osier M, Shukla GS, Lee CH, Chiu J-F, Hart BA: Suppressed oxidant-induced apoptosis in cadmium-adapted alveolar epithelial cells and its potential involvement in cadmium carcinogenesis. Toxicology 147: 215–228, 2000
Shukla GS, Hussain T, Srivatsava RS, Chandra SV: Glutathione peroxidase and catalase in liver, kidney, testis and brain regions of rats following cadmium exposure and subsequent withdrawal. Ind Health 27: 59–69, 1989
Li Q, Hu N, Daggett MA, Chu WA, Bittel D, Johnson JA, Andrews GK: Participation of upstream stimulator factor (USF) in cadmium-induction of the mouse metallothionein-I gene. Nucleic Acids Res 26: 5182–5189, 1998
Andrews GK: Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol 59: 95–104, 2000
Alam J, Wicks C, Stewart D, Gong P, Touchard C, Otterbein S, Choi AMK, Burow ME, Tou J: Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. J Biol Chem 275: 27694–27702, 2000
Thevenod F, Friedman JM, Katsen AD, Hauser IA: Up-regulation of multidrug resistance p-glycoprotein via nuclear-factor kappa B activation protects kidney proximal tubule cells from cadmium and reactive oxygen species-induced apoptosis. J Biol Chem 275: 1887–1896, 2000
Liao VH, Freedman JH: Cadmium-regulated genes from the nematode Caenorhabditis elegans. Identification and cloning of new cadmium-responsive genes by differential display. J Biol Chem 273: 31962–31970, 1998
Momose Y, Iwahashi H: Bioassay of cadmium using a DNA microarray: Genome-wide expression patterns of Saccharomyces cerevisiae in response to cadmium. Environ Toxicol Chem 20: 2353–2360, 2001
Yamada H, Koizumi S: DNA microarray analysis of human gene expression induced by a non-lethal dose of cadmium. Ind Health 40: 159–166, 2002
Riis B, Rattan SIS, Clark BFC, Merrick WC: Eukaryotic translation elongation factors. TIBS 15: 420–424, 1990
Sonenberg N: Translation factors as effectors of cell growth and tumorigenesis. Curr Opin Cell Biol 5: 955–960, 1993
Sonenberg N: Regulation of translation and cell growth by eIF4E. Biochimie 76: 839–846, 1994
Zimmer SG, DeBenedetti A, Graff JR: Translational control of malignancy: The mRNA cap-binding protein, eIF-4E, as a central regulator of tumor promotion, growth, invasion and metastasis. Anticancer Res 20: 1343–1352, 2000.
Tatsuka M, Mitsui M, Wada A, Nagata H, Nojima H, Okayama H: Elongation factor-1 alpha gene determines susceptibility to transformation. Nature 359: 333–336, 1992
Chi K, Jones DV, Frazier ML: Expression of an elongation factor 1 gamma-related sequence in adenocarcinomas of the colon. Gastroenterology 103: 98–102, 1992
Grant AG, Flomen RM, Tizard MLV, Grant DAW: Differential screening of a human pancreatic adenocarcinoma lambda gt11 expression library has identified increased transcription of elongation factor EF-1alpha in tumor cells. Int J Cancer 51: 740–745, 1992
Lew Y, Jones DV, Mars WM, Evans D, Byrd D, Frazier ML: Expression of elongation factor-1 gamma-related sequence in human pancreatic cancer. Pancreas 7: 144–152, 1992
Ender B, Lynch P, Kim YH, Inamdar NV, Cleary KR, Frazier ML: Overexpression of an elongation factor-1 gamma hybridizing RNA in colorectal adenomas. Mol Carcinogenesis 7: 18–20, 1993
Sanders J, Raggiaschi R, Morales J, Moller W: The human leucine zipper-containing guanine-nucleotide exchange protein elongation factor-1 delta. Biochim Biophys Acta 1174: 87–90, 1993
Kerekatte V, Smiley K, Hu B, Smith A, Gelder F, De Benedetti A: The proto-oncogene/translation factor eIF4E: A survey of its expression in breast carcinomas. Int J Cancer 64: 27–31, 1995
Miyagi Y, Sugiyama A, Asai A, Okazaki T, Kuchino Y, Kerr SJ: Elevated levels of eukaryotic translation factor eIF4E mRNA in a broad spectrum of transformed cell lines. Cancer Lett 91: 247–252, 1995
Shen R, Su Z-Z, Olsson CA, Fisher PB: Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc Natl Acad Sci USA 92: 6778–6782, 1995
Eberle J, Krasagakis K, Orfanos CE: Translation initiation factor eIF4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer, 71: 396–401, 1997
De Benedetti A, Harris AL: eIF4E expression in tumors: Its possible role in progression of malignancies. Int J Biochem Cell Biol 31: 59–72, 1999
Shuda M, Kondoh N, Tanaka K, Ryo A, Wakatsuki T, Hada A, Goseki N, Igari T, Hatsuse K, Aihara T, Horiuchi S, Shichita M, Yamamoto N, Yamamoto M: Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res 20: 2489–2494, 2000
Song JM, Picologlou S, Grant CM, Firoozan M, Tuite MF, Liebamn S: Elongation factor EF-1 alpha gene dosage alters translational fidelity in Saccharomyces cerevisiae. Mol Cell Biol 9: 4571–4575, 1989
Carr-Schmid A, Durko N, Cavallius J, Merrick WC, Kinzy TG: Mutations in a GTP-binding motif of eukaryotic elongation factor 1A reduce both translational fidelity and the requirement for nucleotide exchange. J Biol Chem 274: 30297–30302, 1999
Cavallius J, Rattan SIS, Clark BFC: Changes in activity and amount of active elongation factor 1 alpha in aging and immortal human fibroblast cultures. Exp Gerontol 21: 149–157, 1986
Sheperd JCW, Waldorf U, Hug P, Gehring WJ: Fruit flies with additional expression of the elongation factor EF-1 alpha live longer. Proc Natl Acad Sci USA 86: 7520–7521, 1989
Gopalakrishnan RV, Su Z-Z, Goldstein NI, Fisher PB: Translational infidelity and human cancer: Role of the PTI-1 oncogene. Int J Biochem Cell Biol 31: 151–162, 1999
Edmonds BT, Wyckoff J, Yeung YG, Wang Y, Stanly ER, Jones J, Segall J, Condeelis J: Elongation factor-1 alpha is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma. J Cell Sci 109: 2705–2714, 1986
Rosenwald IB, Karatzas N, Sonenberg N, Schmidt EV: Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor eIF4E. Mol Cell Biol 13: 7358–7363, 1993
Rousseau D, Kasper R, Rosenwald I, Gehrke L, Sonenberg M: Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc Natl Acad Sci USA 93: 1065–1070, 1996
Lazaris-Karatzas A, Smith MR, Frederickson RM, Jaramillo ML, Liu YL, Kung HF, Sonenberg N: Ras mediates translation initiation factor-induced malignant transformation. Genes Dev 6: 1631–164, 1992
Saito H, Hayday AC, Wiman K, Hayward WS, Tonegawa S: Activation of the c-myc gene by translocation: A model for translational control. Proc Natl Acad Sci USA 80: 7476–7480, 1983
De Benedetti A, Joshi B, Graff JR, Zimmer SG: CHO cells transformed by the translation factor eIF4E display increased c-myc expression, but require overexpression of Max for tumorigenicity. Mol Cell Diff 2: 347–371, 1994
Flynn A, Proud CG: The role of eIF4E in cell proliferation. Cancer Surveys 27: 293–310, 1996
Rhoads RE: Protein synthesis, cell growth and oncogenesis. Curr Opin Cell Biol 3: 1019–1024, 1991
Rosenwald IB: Deregulation of protein synthesis as a mechanism of neoplastic transformation. Bioessays 18: 77–82, 1996
Fakuchi-Shimogori T, Ishii I, Kashiwagi K, Mashiba H, Ekimoto H, Igarashi K: Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res 57: 5041–5044, 1997
Clemens MJ, Bommer UA: Translational control: The cancer connection. Int J Biochem Cell Biol 31: 1–23, 1999
Misra UK, Gawdi G, Akabani G, Pizzo SV: Cadmium-induced DNA synthesis and cell proliferation in macrophages: The role of intracellular calcium and signal transduction mechanisms. Cell Signal 14: 327–340, 2002
Lee SA, Dritschilo A, Jung M: Role of ATM in oxidative stress-mediated c-jun phosphorylation in response to ionizing radiation and CdCl2. J Biol Chem 276: 11783–11790, 2001
Rinker-Schaeffer CW, Graff JR, De Benedetti A, Zimmer SG, Rhoads RE: Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts. Int J Cancer 55: 841–847, 1993
Shantz LM, Pegg AE: Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res 54: 2313–2316, 1996
Su Z, Goldstein NI, Fisher PB: Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes. Proc Natl Acad Sci USA 95: 1764–1769, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Joseph, P., Lei, YX. & Ong, Tm. Up-regulation of expression of translation factors – a novel molecular mechanism for cadmium carcinogenesis. Mol Cell Biochem 255, 93–101 (2004). https://doi.org/10.1023/B:MCBI.0000007265.38475.f7
Issue Date:
DOI: https://doi.org/10.1023/B:MCBI.0000007265.38475.f7